デフォルト表紙
市場調査レポート
商品コード
1279868

ウイルスクリアランスサービスの世界市場規模調査&予測:方法別、用途別、エンドユーザー別、地域別分析、2023-2030年

Global Viral Clearance Services Market Size study & Forecast, by Method, by Application, by End-User, and Regional Analysis, 2023-2030

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ウイルスクリアランスサービスの世界市場規模調査&予測:方法別、用途別、エンドユーザー別、地域別分析、2023-2030年
出版日: 2023年05月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

組換えタンパク質、糖タンパク質、組織・血液由来製品、医薬品デバイス、モノクローナル抗体などの生成は、すべてウイルスクリアランスプロセスに依存しています。

これは、これらの品目に細菌や真菌の汚染、化学物質の汚染、ウイルスの汚染の可能性があることから説明されます。ウイルスの安全対策の市場は、ウイルスクリアランスと評価プロセスが製品安全における重要な段階であるため、その影響を受けます。市場の成長は、ウイルスクリアランスのニーズの高まり、特殊医薬品の需要の増加、研究開発資金の増加によって促進されます。

また、米国では医薬品に対する資金調達が活発化していることも、本分野の拡大を後押ししています。アメリカの製薬業界では、毎年、重要な臨床効果を持つさまざまな新薬が開発されています。これらの医薬品の多くは高価であり、連邦政府と民間部門の両方の医療費が増加しています。米国連邦政府は、Operation Warp SpeedとBiomedical Advanced Research and Research Authorityを通じて、後期ワクチン研究と2020年の製造能力増強に向けて110億米ドルを資金提供しました。さらに、製薬およびバイオテクノロジー産業における需要の成長とM&Aの増加は、長年にわたる市場機会を強化します。しかし、前臨床手順のアウトソーシングに関する承認の欠如は、2023年から2030年の予測期間を通じて市場の成長を阻害します。

ウイルスクリアランスサービスの世界市場調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、その他ラテンアメリカです。北米地域は、多くの製薬会社やバイオテクノロジー企業の存在、研究開発活動に対する政府資金の増加、確立されたヘルスケアインフラにより、現在ウイルスクリアランスサービス市場を独占しています。しかし、アジア太平洋地域は、ウイルスクリアランスサービス市場において最も急速に成長している地域であると予想されます。この地域の成長は、バイオ医薬品の需要の増加、CRO(契約研究機関)の増加、中国やインドなどの国々へのバイオ医薬品製造のアウトソーシングの増加に起因していると考えられます。

本調査の目的は、近年におけるさまざまなセグメントおよび国の市場規模を明らかにし、今後数年間の市場規模を予測することにあります。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界市場・セグメント別市場推計・予測、2020-2030年
    • ウイルスクリアランスサービス市場、地域別、2020-2030年
    • ウイルスクリアランスサービス市場:方法別、2020-2030年
    • ウイルスクリアランスサービス市場:用途別、2020年~2030年
    • ウイルスクリアランスサービス市場:エンドユーザー別、2020年~2030年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 ウイルスクリアランスサービスの世界市場の定義と範囲

  • 調査目的
  • 市場の定義とスコープ
    • 業界の進化
    • 本調査の対象範囲
  • 調査対象年
  • 通貨換算レート

第3章 ウイルスクリアランスサービスの世界市場力学

  • ウイルスクリアランスサービス市場のインパクト分析(2020年~2030年)
    • 市場促進要因
      • ウイルスクリアランスのニーズの高まり
      • スペシャリティドラッグの需要拡大
      • 研究開発資金の増加
    • 市場の課題
      • 前臨床試験のアウトソーシングに対する認可の欠如
    • 市場機会
      • 製薬およびバイオテクノロジー産業における需要の増加
      • M&A件数の増加

第4章 世界のウイルスクリアランスサービス市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースインパクト分析
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
    • 環境
    • 法律
  • トップ投資機会
  • 主要成功戦略
  • COVID-19影響度分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの提言と結論

第5章 ウイルスクリアランスサービスの世界市場:方法別

  • 市場スナップショット
  • ウイルスクリアランスサービスの世界市場:方法別、実績、ポテンシャル分析
  • ウイルスクリアランスサービスの世界市場、方法別推定・予測(2020年~2030年
  • ウイルスクリアランスサービス市場、サブセグメント別分析
    • ウイルスの除去
    • ウイルスの不活性化

第6章 ウイルスクリアランスサービスの世界市場:用途別

  • 市場スナップショット
  • ウイルスクリアランスサービスの世界市場:用途別、実績・ポテンシャル分析
  • ウイルスクリアランスサービスの世界市場、用途別推定・予測2020-2030
  • ウイルスクリアランスサービス市場、サブセグメント別分析
    • 遺伝子組換えタンパク質
    • 組織・血液由来製品
    • ワクチン
    • その他

第7章 ウイルスクリアランスサービスの世界市場:エンドユーザー別

  • マーケットスナップショット
  • ウイルスクリアランスサービスの世界市場:エンドユーザー別実績・ポテンシャル分析
  • ウイルスクリアランスサービスの世界市場、エンドユーザー別推定・予測2020-2030
  • ウイルスクリアランスサービス市場、サブセグメント分析
    • バイオ医薬品
    • 契約研究機関
    • 学術研究機関

第8章 ウイルスクリアランスサービスの世界市場:地域別分析

  • 上位の主要国
  • 上位新興国
  • ウイルスクリアランスサービス市場、地域別市場スナップショット
  • 北米
    • 米国
      • 方法別の推定・予測、2020-2030年
      • 用途別の推定・予測、2020-2030年
      • エンドユーザーの内訳の推定と予測、2020-2030年
    • カナダ
  • 欧州ウイルスクリアランスサービス市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域のウイルスクリアランスサービス市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのウイルスクリアランスサービス市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカのウイルスクリアランスサービス市場
    • サウジアラビアのウイルスクリアランスサービス市場
    • 南アフリカ共和国のウイルスクリアランスサービス市場
    • その他中東とアフリカのウイルスクリアランスサービス市場

第9章 競合情報

  • 主要企業のSWOT分析
  • トップ市場戦略
  • 企業プロファイル
    • Vironova AB
      • 主要情報
      • 概要
      • 財務情報(データ提供可能な場合のみ)
      • 方法の概要
      • 最近の動向
    • Charles River Laboratories, Inc.
    • Labor Dr. Merk & Kollegen GmbH
    • Merck KGaA
    • Texcell SA
    • WuXi AppTec
    • Sartorius AG
    • Eurofins Scientific
    • Bioscience Laboratories

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Viral Clearance Services Market, report scope
  • TABLE 2. Global Viral Clearance Services Market estimates & forecasts by region 2020-2030 (USD Billion)
  • TABLE 3. Global Viral Clearance Services Market estimates & forecasts by Method 2020-2030 (USD Billion)
  • TABLE 4. Global Viral Clearance Services Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global Viral Clearance Services Market estimates & forecasts by End User 2020-2030 (USD Billion)
  • TABLE 6. Global Viral Clearance Services Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Viral Clearance Services Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Viral Clearance Services Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Viral Clearance Services Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Viral Clearance Services Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Viral Clearance Services Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Viral Clearance Services Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Viral Clearance Services Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Viral Clearance Services Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Viral Clearance Services Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Viral Clearance Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Viral Clearance Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Viral Clearance Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Viral Clearance Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Viral Clearance Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Viral Clearance Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Viral Clearance Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Viral Clearance Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Viral Clearance Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Viral Clearance Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Viral Clearance Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Viral Clearance Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Viral Clearance Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Viral Clearance Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Viral Clearance Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Viral Clearance Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Viral Clearance Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Viral Clearance Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Viral Clearance Service Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Viral Clearance Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Viral Clearance Service Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Viral Clearance Services Market
  • TABLE 71. List of primary sources, used in the study of global Viral Clearance Services Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Viral Clearance Services Market, research methodology
  • FIG 2. Global Viral Clearance Services Market, Market estimation End Users
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Viral Clearance Services Market, key trends 2023
  • FIG 5. Global Viral Clearance Services Market, growth prospects 2023-2030
  • FIG 6. Global Viral Clearance Services Market, porters 5 force model
  • FIG 7. Global Viral Clearance Services Market, pest analysis
  • FIG 8. Global Viral Clearance Services Market, value chain analysis
  • FIG 9. Global Viral Clearance Services Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Viral Clearance Services Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Viral Clearance Services Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Viral Clearance Services Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Viral Clearance Services Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Viral Clearance Services Market, regional snapshot 2020 & 2030
  • FIG 15. North America Viral Clearance Services Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Viral Clearance Services Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Viral Clearance Services Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Viral Clearance Services Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Viral Clearance Services Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than 15% over the forecast period 2023-2030. The generation of recombinant proteins, glycoproteins, tissue- and blood-derived products, medicinal devices, and monoclonal antibodies all depend on the viral clearance process. This is explained by the possibility of bacterial and fungal contamination, chemical contaminants, and viral contamination in these items. The market for viral safety practices is influenced by the viral clearance and assessment processes since they are important phases in product safety. The market growth is propelled by the increasing need for Viral Clearance, growing Demand for Specialty Drugs and rise in Research and Development Funding.

The expansion of the industry under study is further aided by increased financing for medicines across the United States. The American pharmaceutical sector annually develops a wide variety of novel drugs with important clinical benefits. Many of those drugs are expensive, which raises the expense of healthcare for both the federal government and the private sector. Through Operation Warp Speed and the Biomedical Advanced Research and Research Authority, the federal government in the United States funded USD 11 billion towards late-stage vaccine research and an increase in manufacturing capacity in 2020. Moreover, growth in demand in pharmaceutical and biotechnological industries and an increase in the number of mergers and acquisitions enhance the market opportunities over the years. However, the lack of Approval for Outsourcing of Preclinical Procedures stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Viral Clearance Services Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. The North American region is currently dominating the viral clearance services market due to the presence of many pharmaceutical and biotech companies, growing government funding for research and development activities, and a well-established healthcare infrastructure. However, the Asia-Pacific region is expected to be the fastest-growing region in the viral clearance services market. The growth in this region can be attributed to the increasing demand for biopharmaceuticals, the growing number of Contract Research Organizations (CROs), and the increasing outsourcing of biopharmaceutical manufacturing to countries such as China and India

Major market players included in this report are:

  • Charles River Laboratories, Inc.
  • Labor Dr. Merk & Kollegen GmbH
  • Merck KGaA
  • Texcell SA
  • WuXi AppTec
  • Sartorius AG
  • Eurofins Scientific
  • Bioscience Laboratories
  • Vironova AB

Recent Developments in the Market:

  • In September 2022, Merck inaugurated a viral clearance (VC) lab as a part of the initial construction phase of its new EUR 29 million China Biologics Testing Centre.
  • In April 2022, Abzena, a partner research organisation (PRO), =announced the launch of a biologics testing facility close to the company's biologics process development and manufacturing base in San Diego, California. Partners will have access to viral clearance studies, cell-based and PCR safety testing, and IND, IMPD, BLA, and MAA submissions through the facility.

Global Viral Clearance Services Market Report Scope:

  • Historical Data: - 2020 - 2021
  • Base Year for Estimation: - 2022
  • Forecast period: - 2023-2030
  • Report Coverage: - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: - Method, Application, End user, Region
  • Regional Scope: - North America; Europe; Asia Pacific; Latin America; Middle East Africa
  • Customization Scope: - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Method:

  • Viral Removal
  • Viral Inactivation

By Application:

  • Recombinant Proteins
  • Tissue and Blood Derived Products
  • Vaccines
  • Other

By End User:

  • Biopharmaceuticals
  • Contract Research Organizations
  • Academic Research Institutes

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Viral Clearance Services Market, by region, 2020-2030 (USD Billion)
    • 1.2.2. Viral Clearance Services Market, by Method, 2020-2030 (USD Billion)
    • 1.2.3. Viral Clearance Services Market, by Application, 2020-2030 (USD Billion)
    • 1.2.4. Viral Clearance Services Market, by End User, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Viral Clearance Services Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Viral Clearance Services Market Dynamics

  • 3.1. Viral Clearance Services Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing Need for Viral Clearance
      • 3.1.1.2. Growing Demand for Specialty Drugs
      • 3.1.1.3. Rise in Research and Development Funding
    • 3.1.2. Market Challenges
      • 3.1.2.1. Lack of Approval of Outsourcing of Preclinical Procedures
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growth in demand in pharmaceutical and biotechnological industries
      • 3.1.3.2. Increase in number of mergers and acquisitions

Chapter 4. Global Viral Clearance Services Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Viral Clearance Services Market, by Method

  • 5.1. Market Snapshot
  • 5.2. Global Viral Clearance Services Market by Method, Performance - Potential Analysis
  • 5.3. Global Viral Clearance Services Market Estimates & Forecasts by Method 2020-2030 (USD Billion)
  • 5.4. Viral Clearance Services Market, Sub Segment Analysis
    • 5.4.1. Viral Removal
    • 5.4.2. Viral Inactivation

Chapter 6. Global Viral Clearance Services Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Viral Clearance Services Market by Application, Performance - Potential Analysis
  • 6.3. Global Viral Clearance Services Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Viral Clearance Services Market, Sub Segment Analysis
    • 6.4.1. Recombinant Proteins
    • 6.4.2. Tissue and Blood Derived Products
    • 6.4.3. Vaccines
    • 6.4.4. Others

Chapter 7. Global Viral Clearance Services Market, by End User

  • 7.1. Market Snapshot
  • 7.2. Global Viral Clearance Services Market by End User, Performance - Potential Analysis
  • 7.3. Global Viral Clearance Services Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
  • 7.4. Viral Clearance Services Market, Sub Segment Analysis
    • 7.4.1. Biopharmaceuticals
    • 7.4.2. Contract Research Organizations
    • 7.4.3. Academic Research Institutes

Chapter 8. Global Viral Clearance Services Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Viral Clearance Services Market, Regional Market Snapshot
  • 8.4. North America Viral Clearance Services Market
    • 8.4.1. U.S. Viral Clearance Services Market
      • 8.4.1.1. Method breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Viral Clearance Services Market
  • 8.5. Europe Viral Clearance Services Market Snapshot
    • 8.5.1. U.K. Viral Clearance Services Market
    • 8.5.2. Germany Viral Clearance Services Market
    • 8.5.3. France Viral Clearance Services Market
    • 8.5.4. Spain Viral Clearance Services Market
    • 8.5.5. Italy Viral Clearance Services Market
    • 8.5.6. Rest of Europe Viral Clearance Services Market
  • 8.6. Asia-Pacific Viral Clearance Services Market Snapshot
    • 8.6.1. China Viral Clearance Services Market
    • 8.6.2. India Viral Clearance Services Market
    • 8.6.3. Japan Viral Clearance Services Market
    • 8.6.4. Australia Viral Clearance Services Market
    • 8.6.5. South Korea Viral Clearance Services Market
    • 8.6.6. Rest of Asia Pacific Viral Clearance Services Market
  • 8.7. Latin America Viral Clearance Services Market Snapshot
    • 8.7.1. Brazil Viral Clearance Services Market
    • 8.7.2. Mexico Viral Clearance Services Market
  • 8.8. Middle East & Africa Viral Clearance Service Market
    • 8.8.1. Saudi Arabia Viral Clearance Service Market
    • 8.8.2. South Africa Viral Clearance Service Market
    • 8.8.3. Rest of Middle East & Africa Viral Clearance Service Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Vironova AB
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Method Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Charles River Laboratories, Inc.
    • 9.3.3. Labor Dr. Merk & Kollegen GmbH
    • 9.3.4. Merck KGaA
    • 9.3.5. Texcell SA
    • 9.3.6. WuXi AppTec
    • 9.3.7. Sartorius AG
    • 9.3.8. Eurofins Scientific
    • 9.3.9. Bioscience Laboratories

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption